Navigation Links
Ceres Announces Fiscal Year 2013 Financial Results

nts. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products, short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Ceres' views as of any date subsequent to the date of this press release.CERES, INC. AND SUBSIDIARYCondensed Consolidated Statements of Operations (In thousands, except share and per share amounts)(Unaudited) Three Months Ended
August 31,  Year Ended
August 31, 2013201220132012Revenues:Product sales 

432Collaborative research and government grants 

8981,1614,7814,939Total revenues 

8981,1645,2435,371Cost and operating expenses:Cost of product sales 

1,1325076,2452,384Research and development 

3,6173,63416,40119,155Selling, general and administrative 

3,4883,67315,18712,634Total cost and operating expenses 

8,2377,81437,83334,173Loss from operations 

(7,339)(6,650)(32,590)(28,802)Interest expense 

(11)(1)(46)(560)Interest income 

193012639Other expense

———(84)Loss before income taxes 


SOURCE Ceres, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
2. Ceres Receives $3.5 million from USAID for Trait Stacks
3. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
4. Ceres Announces Webcast of Fiscal Year 2013 Financial Results
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
6. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
7. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
8. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
9. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
10. WuXi PharmaTech Announces Third-Quarter 2011 Results
11. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
Post Your Comments:
(Date:8/18/2014)... 18, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a ... and products for advanced microarray diagnostics, today announced it ... 22 at 2:00 pm ET.  During ... a brief review of SQI,s recent commercialization progress and ... industry veteran recently appointed to the Board of Directors ...
(Date:8/18/2014)... WASHINGTON , Aug. 18, 2014   Sterne, ... law firm in Washington, DC , ... Inter Partes Review (IPR) with the U.S. ... Inc., a subsidiary of BioReference Laboratories, Inc. (Nasdaq: BRLI). ... co-owned, or licensed by Myriad Genetics, Inc. These patents ...
(Date:8/18/2014)... HIV Infection Drug Market and Pipeline Insight is a ... infection and the number of deaths due to AIDS has ... the globe. It has been estimated that the death rate ... with the rates for children being even much lower. A ... has been the improved access to antiretroviral drugs and therapy ...
(Date:8/18/2014)... 2014 According to the ... Application (Municipal Wastewater Treatment and Industrial Wastewater Treatment), ... Tubular), By Configuration (Internal/Submerged and External/Sidestream), and By ... The market for membrane bioreactor systems is projected ... a CAGR of 15.28% between 2014 and 2019. ...
Breaking Biology Technology:SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3
... 9, 2011 SPX Corporation (NYSE: SPW ... of B.W. Murdoch Ltd, a leading engineering company supplying ... company is based in Auckland, New Zealand. Terms of ... team has decades of experience in the New Zealand ...
... Md., March 9, 2011 The evidenced-based behavioral health ... Apple iPad; provides the clinician immediate clinical decision support ... is the first behavioral health site of its ... support for clinicians, and longitudinal monitoring for continuing care," ...
... 8, 2011 Leading events organiser UBM Live ... today announced details of the anticipated content and new developments ... leading International pharmaceutical event, being held from 18-20 April, 2011 ... line-up of events surrounding CPhI Japan includes P-MEC Japan, which ...
Cached Biology Technology:SPX Announces Acquisition of B.W. Murdoch Ltd, Broadening Process Engineering and Project Management Capabilities in New Zealand and the Asia Pacific Region 2M-3 Information, a Leader in Expert Behavioral Health Solutions, Launches 2UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 2UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 3UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 4
(Date:8/19/2014)... concentrations of African dust transported to South America ... These research findings offer new insight on the ... African dust, including the climate change-induced human health ... African dust emissions in the coming decades., Researchers ... of Marine and Atmospheric Science and colleagues analyzed ...
(Date:8/19/2014)... forms, they have not been widely used due to ... the University of Surrey and Trinity College Dublin have ... graphene, to create a flexible sensor that is sensitive ... , Once treated, the rubber bands remain highly ... imparts an electromechanical response on movement the team ...
(Date:8/18/2014)... bacterial species in a person,s gut may protect against ... common cause of human bacterial intestinal inflammation, according research ... open-access journal of the American Society for Microbiology. The ... yield lasting changes to one,s gut bacteria composition. , ... the microbiota, or microorganisms in the gut, can protect ...
Breaking Biology News(10 mins):Study of African dust transport to South America reveals air quality impacts 2What's in your gut? Certain bacteria may influence susceptibility to infection 2
... announces that a new market research report ... US Biologics  Market ... exceed $100 billion by 2015 ... in 2015, experiencing continuing strong growth following a ...
... A new insight into global photosynthesis, the chemical process governing ... has been revealed in research that will assist scientists to ... published today in Nature , a team of US, ... of photosynthesis, the chemical process governing the way ocean and ...
... expert opinion of over 10,000 internationally renowned scientists and clinicians, ... looking at the research literature. A measure of how scientists ... rating system of articles, where named F1000 members score research ... these to generate a score for each journal that has ...
Cached Biology News:US Biologics Market 2US Biologics Market 3US Biologics Market 4US Biologics Market 5US Biologics Market 6US Biologics Market 7A new leaf turns in carbon science 2A new leaf turns in carbon science 3Faculty of 1000 introduces a unique opinion-based journal metric 2
... Early Drug Development with Imaging Mass Spectrometry ... compound localization data in early drug development ... spectrometry service maps unlabeled ions ... you can localize drugs and metabolites prior ...
... The AccuSpot automates LC micro-fractionation, ... With the AccuSpot system, LC eluent ... onto target plates, in trace amounts. ... target plates for MALDI-TOF-MS measurements. When ...
... The JNK (c-Jun NH2-terminal kinase) ... three identified MAP kinase pathways in ... response to environmental stress, is associated ... itself, and is implicated in the ...
... knockdown of all human, mouse, and ... Genomewide, predesigned siRNAs for a ... , Ready-to-use, convenient matching solutions for ... Cost-effective RNAi and downstream analysis ...
Biology Products: